$69 Million - Follow-OnJoint Bookrunner
Solid Biosciences Inc.
$60 Million - Private PlacementExclusive Placement Agent
$209 Million - Initial Public OfferingJoint Bookrunner
Biopharma / Are Generic Deflation Trends Finally Starting to Improve?
ABBV / Upgrading the New Cash King – More Diversified, More Durable, Cheaper, OP, $88 / Outperform
Biopharma / American Psychiatric Association (APA) 2019: Core Takeaways and Industry Themes